Development of fluorescent and class selective HDAC Inhibitors


Autoria(s): Fleming, Cassandra
Contribuinte(s)

Pfeffer, Frederick

Data(s)

01/02/2015

Resumo

 The inhibition of HDAC enzymes has proven beneficial for the treatment of a variety of diseases including cancer. This thesis details the development of class selective and fluorescent HDAC inhibitors for cellular imaging. Increased HDAC and anticancer activities were observed, and the fluorescent inhibitors were readily visualised in live cells.

Identificador

http://hdl.handle.net/10536/DRO/DU:30074274

Idioma(s)

eng

Publicador

Deakin University, Faculty of Science, Engineering and Built Environment, School of Life and Environmental Sciences

Relação

http://dro.deakin.edu.au/eserv/DU:30074274/fleming-agreement-2015.pdf

http://dro.deakin.edu.au/eserv/DU:30074274/fleming-development-2015.pdf

Direitos

The author

Palavras-Chave #histone deacetylase (HDAC) enzymes #cancer therapy #fluorescent inhibitors #cellular imaging
Tipo

Thesis